The effect of timing and graft dysfunction on survival and cardiac allograft vasculopathy in antibody-mediated rejection

Late AMR is frequently associated with graft dysfunction. When graft dysfunction is present in late AMR, there is an early and sustained increased risk of death and rapid development of de novo CAV despite aggressive treatment.